S256: TABELECLEUCEL FOR EBV-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE OF RITUXIMAB ± CHEMOTHERAPY (ALLELE)

oleh: S. Prockop, MD, A. Beitinjaneh, MD, S. Choquet, MD, S. Dahiya, MD, R. Dinavahi, MD, R. Farah, MD, L. Gamelin, MD, PhD, A. Ghobadi, MD, A. Mehta, P. Nayak, MD, R. Reshef, MD, G. Satyanarayana, MD, P. Stiff, MD, W. Ye, PhD, K. M. Mahadeo, MD, MPH